The Company anticipates continued profitability and positive cash flow, targeting operating income of 13% to 14% and Adjusted EBITDA of $12 to $14 million.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- Brainsway’s New Deep TMS Depression Study Completion: What Investors Should Watch Next
- BWAY Upcoming Earnings Report: What to Expect?
- BrainsWay Unveils Landmark Data on Accelerated Deep TMS for Depression
- Brainsway announces new data on noninvasive way to treat depression
- BrainsWay Takes Minority Stake in Canadian Mental Health Provider BrainStim Health